[42D1-42D1];[42E5-42E5];
A set of ~800 largely isogenic deficiency stocks created by FLP-induced recombination between FRT-carrying transgenic insertions; molecularly defined deletion endpoints correspond to initial location of the progenitor insertions. Designed to fill gaps in deletion coverage and breakpoint placement; also used to replace older available deficiencies that have not been molecularly mapped.
42D1;42E5
Breakpoint based on release 3 sequence coordinate from Thibault et al., 2004, Supplementary Table 2 (FBrf0174227) or 3 (FBrf0174228), converted to release 5 coordinate.
Breakpoint from FlyBase's release 5 sequence location of progenitor insertion.
Lethal in combination with Df(2R)Exel6050.
Df(2R)EpacΔ1/Df(2R)BSC261 animals are viable and fertile.
Df(2R)EpacΔ3/Df(2R)BSC261 animals die as first instar larvae.
Inferred to overlap with: Df(2R)Exel6051.
The presence of P+PBac{XP5.RB3}BSC261 was verified using the PCR methods and primers described in FBrf0175003.
Exelixis, Inc. determined the insertion site of P{XP}d06988 to be at Release 3 genomic coordinate 2085948 on chromosome arm 2R. This corresponds to 42E5 on Release 3 and 4 genome map2. The predicted position of PBac{RB}Epace01145 on the Release 4 map is 42D1. Consequently, the cytological breakpoints of Df(2R)BSC261 are predicted to be 42D1;42E5.